<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Radic J</submitter><funding>European Regional Development Fund</funding><pagination>2418</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12561152</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(10)</volume><pubmed_abstract>&lt;b>Background/Objectives:&lt;/b> Cardiometabolic risk remains a major challenge in patients with type 2 diabetes mellitus (DMT2). This study aimed to evaluate cardiovascular (CV) risk stratification using advanced glycation end-products (AGEs) measured via skin autofluorescence (SAF) and to assess the achievement of evidence-based ABC targets (HbA1c, blood pressure, low-density lipoprotein (LDL) cholesterol) in adults with DMT2 in Dalmatia. &lt;b>Methods:&lt;/b> In this single-center cross-sectional study, 251 adults with DMT2 were stratified by CV risk based on SAF measured AGE levels. Clinical, biochemical, and anthropometric data were collected, including ABC goal attainment and medication use. Statistical analyses compared groups and explored predictors of ABC target achievement using regressio</pubmed_abstract><journal>Biomedicines</journal><pubmed_title>Public Health Screening for Cardiometabolic Risk: Lessons from Advanced Glycation End-Products and ABC Target Achievement in Dalmatian Adults with Type 2 Diabetes.</pubmed_title><pmcid>PMC12561152</pmcid><funding_grant_id>KK.01.1.1.04.0115.</funding_grant_id><pubmed_authors>Đogas H</pubmed_authors><pubmed_authors>Odeverp A</pubmed_authors><pubmed_authors>Grubic M</pubmed_authors><pubmed_authors>Radic M</pubmed_authors><pubmed_authors>Radic J</pubmed_authors><pubmed_authors>Vuckovic M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Public Health Screening for Cardiometabolic Risk: Lessons from Advanced Glycation End-Products and ABC Target Achievement in Dalmatian Adults with Type 2 Diabetes.</name><description>&lt;b>Background/Objectives:&lt;/b> Cardiometabolic risk remains a major challenge in patients with type 2 diabetes mellitus (DMT2). This study aimed to evaluate cardiovascular (CV) risk stratification using advanced glycation end-products (AGEs) measured via skin autofluorescence (SAF) and to assess the achievement of evidence-based ABC targets (HbA1c, blood pressure, low-density lipoprotein (LDL) cholesterol) in adults with DMT2 in Dalmatia. &lt;b>Methods:&lt;/b> In this single-center cross-sectional study, 251 adults with DMT2 were stratified by CV risk based on SAF measured AGE levels. Clinical, biochemical, and anthropometric data were collected, including ABC goal attainment and medication use. Statistical analyses compared groups and explored predictors of ABC target achievement using regressio</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-05-14T03:18:25.254Z</modification><creation>2026-05-14T03:12:14.368Z</creation></dates><accession>S-EPMC12561152</accession><cross_references><pubmed>41153701</pubmed><doi>10.3390/biomedicines13102418</doi></cross_references></HashMap>